Information Library

Clinical Pharmacology

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Turnkey TQT Solutions

    April 13, 2010
    At Quintiles, we offer you a complete solution for your TQT needs including our Phase I, Clinical Pharmacology and ECG Core Labs.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA

    November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.

  • QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH

    October 26, 2009 - A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide.

  • Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy

    June 29, 2009
    The project pooled blinded data from existing completed clinical trials contributed by Eli Lilly and Company, GlaxoSmithKline, Hoffmann-LaRoche, Inc, and Merck Research Laboratories into a single database hosted by Quintiles Transnational Corporation.

  • Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.

    June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.”

Page 1 of 1 (6 results)

Subscribe to Email Based on Your Interests

Set preferences